Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines

Karen Bräutigam(Universitäres Kinderwunschzentrum Lübeck), Frank Köster(Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR))
Journal of Cancer Research and Clinical Oncology
June 29, 2021
Cited by 18


Related Papers